ADAP Insider Trading

Insider Ownership Percentage: 17.37%
Insider Buying (Last 12 Months): $11,310.00
Insider Selling (Last 12 Months): $183,195.16

Adaptimmune Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Adaptimmune Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adaptimmune Therapeutics Share Price & Price History

Current Price: $1.20
Price Change: Price Increase of +0.03 (2.56%)
As of 09/26/2022 03:34 PM ET

This chart shows the closing price history over time for ADAP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Adaptimmune Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/1/2022Adrian RawcliffeCEOSell2,536$1.97$4,995.923,316View SEC Filing Icon  
8/1/2022John LungerInsiderSell2,983$1.77$5,279.914,829View SEC Filing Icon  
7/5/2022John LungerInsiderSell1,973$1.68$3,314.643,104View SEC Filing Icon  
6/27/2022Adrian RawcliffeCEOSell2,562$1.63$4,176.063,290View SEC Filing Icon  
5/20/2022Gavin WoodCFOBuy39,000$0.29$11,310.0096,000View SEC Filing Icon  
1/18/2022Adrian RawcliffeCEOSell11,096$3.19$35,396.24View SEC Filing Icon  
1/18/2022Elliot NorryInsiderSell2,121$3.19$6,765.99View SEC Filing Icon  
1/18/2022Willaim C. Bertrand, Jr.COOSell4,368$3.19$13,933.92View SEC Filing Icon  
1/12/2022John LungerInsiderSell1,076$3.54$3,809.04View SEC Filing Icon  
1/11/2022Adrian RawcliffeCEOSell14,362$3.56$51,128.72View SEC Filing Icon  
1/11/2022Willaim C. Bertrand, Jr.COOSell3,770$3.56$13,421.20View SEC Filing Icon  
1/4/2022Adrian RawcliffeCEOSell5,532$4.06$22,459.92View SEC Filing Icon  
1/4/2022John LungerInsiderSell1,070$4.06$4,344.20View SEC Filing Icon  
1/4/2022Willaim C. Bertrand, Jr.COOSell3,490$4.06$14,169.40View SEC Filing Icon  
9/1/2021Adrian RawcliffeCEOSell2,782$5.20$14,466.40View SEC Filing Icon  
8/2/2021John LungerInsiderSell2,939$3.58$10,521.62View SEC Filing Icon  
6/28/2021Adrian RawcliffeCEOSell2,794$4.37$12,209.78View SEC Filing Icon  
1/19/2021Adrian RawcliffeCEOSell9,879$5.67$56,013.93View SEC Filing Icon  
1/19/2021Elliot NorryInsiderSell2,111$5.67$11,969.37View SEC Filing Icon  
1/12/2021Adrian RawcliffeCEOSell2,707$6.15$16,648.05View SEC Filing Icon  
1/12/2021John LungerInsiderSell1,058$6.15$6,506.70View SEC Filing Icon  
1/12/2021William C. Bertrand, Jr.COOSell2,234$6.15$13,739.10View SEC Filing Icon  
1/4/2021Adrian RawcliffeCEOSell4,967$5.33$26,474.11View SEC Filing Icon  
1/4/2021John LungerInsiderSell1,065$5.33$5,676.45View SEC Filing Icon  
1/4/2021William C. Bertrand, Jr.COOSell3,499$5.33$18,649.67View SEC Filing Icon  
12/14/2020Gavin WoodCFOBuy24,000$0.69$16,560.00View SEC Filing Icon  
12/14/2020William C. Bertrand, Jr.COOBuy207,000$0.69$142,830.00View SEC Filing Icon  
9/1/2020Adrian RawcliffeCEOSell2,776$8.51$23,623.76View SEC Filing Icon  
8/3/2020Adrian RawcliffeCEOSell2,788$9.25$25,789.00View SEC Filing Icon  
8/3/2020John LungerInsiderSell4,823$9.25$44,612.75View SEC Filing Icon  
6/29/2020Gavin WoodCFOBuy33,000$1.62$53,460.0033,000View SEC Filing Icon  
6/9/2020Lawrence M. AllevaDirectorBuy12,900$1.89$24,381.00View SEC Filing Icon  
5/29/2020James NobleDirectorSell500,000$9.33$4,665,000.00View SEC Filing Icon  
1/24/2020Peter W SonsiniMajor ShareholderBuy7,500,000$0.67$5,025,000.00View SEC Filing Icon  
1/14/2020Adrian RawcliffeCEOSell3,236$5.13$16,600.68View SEC Filing Icon  
1/14/2020Elliot NorryInsiderSell911$5.13$4,673.43View SEC Filing Icon  
1/14/2020William C. Bertrand, Jr.COOSell2,397$5.13$12,296.61View SEC Filing Icon  
1/13/2020James NobleDirectorSell300,000$4.67$1,401,000.00View SEC Filing Icon  
1/6/2020Adrian RawcliffeCEOSell5,900$1.20$7,080.00View SEC Filing Icon  
1/6/2020John LungerInsiderSell1,148$1.20$1,377.60View SEC Filing Icon  
1/6/2020William C. Bertrand, Jr.COOSell3,731$1.20$4,477.20View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adaptimmune Therapeutics (NASDAQ:ADAP)

70.18% of Adaptimmune Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADAP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adaptimmune Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/22/2022ExodusPoint Capital Management LP300,000$0.51M0.0%N/A0.184%Search for SEC Filing on Google Icon
8/16/2022Jane Street Group LLC44,086$75K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2022State Street Corp366,525$0.62M0.0%-42.8%0.226%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.647,008$1.10M0.0%+11.1%0.399%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC122,122$0.21M0.0%-91.6%0.075%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC17,328$29K0.0%-29.2%0.011%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC510,000$0.87M0.0%-46.9%0.315%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC217,123$0.37M0.0%-59.5%0.134%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.96,110$0.16M0.0%N/A0.059%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.1,474,163$2.51M0.0%+5.3%0.910%Search for SEC Filing on Google Icon
8/10/2022Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018%Search for SEC Filing on Google Icon
8/8/2022Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457%Search for SEC Filing on Google Icon
7/11/2022Vigilare Wealth Management41,800$71K0.1%N/A0.026%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE524,212$1.08M0.0%-2.6%0.324%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC24,470$50K0.0%N/A0.015%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP2,297,194$4.73M0.1%+3.7%1.419%Search for SEC Filing on Google Icon
5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.359,919$0.74M0.0%+16.7%0.229%Search for SEC Filing on Google Icon
5/16/2022State Street Corp640,620$1.32M0.0%+4.2%0.408%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP237,086$0.49M0.0%-32.0%0.151%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC959,703$1.98M0.0%+124.4%0.612%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.1,330,839$2.74M0.0%+13.7%0.848%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC44,208$91K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.21,537$44K0.0%-28.3%0.014%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.1,399,765$2.88M0.0%-5.3%0.892%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP69,612$0.14M0.0%-17.3%0.044%Search for SEC Filing on Google Icon
5/5/2022Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805%Search for SEC Filing on Google Icon
5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011%Search for SEC Filing on Google Icon
4/29/2022Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023%Search for SEC Filing on Google Icon
4/26/2022Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013%Search for SEC Filing on Google Icon
4/21/2022Inspire Investing LLC31,928$66K0.0%+107.4%0.020%Search for SEC Filing on Google Icon
4/21/2022Inspire Advisors LLC45,105$93K0.0%+193.0%0.029%Search for SEC Filing on Google Icon
4/18/2022Key Client Fiduciary Advisors LLC420,447$0.87M0.7%+58.0%0.268%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC136,266$0.51M0.1%N/A0.087%Search for SEC Filing on Google Icon
2/14/2022Eversept Partners LP348,716$1.31M0.1%-21.6%0.223%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP84,129$0.32M0.0%-82.6%0.054%Search for SEC Filing on Google Icon
2/11/2022Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC19,315$72K0.0%-34.0%0.012%Search for SEC Filing on Google Icon
2/7/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$0.28M0.0%+13.6%0.044%Search for SEC Filing on Google Icon
2/3/2022Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016%Search for SEC Filing on Google Icon
2/3/2022Inspire Investing LLC15,393$58K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/27/2022Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007%Search for SEC Filing on Google Icon
1/20/2022Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807%Search for SEC Filing on Google Icon
12/1/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%Search for SEC Filing on Google Icon
11/18/2021Personal CFO Solutions LLC36,388$0.19M0.0%+19.7%0.023%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224%Search for SEC Filing on Google Icon
11/16/2021ACT Capital L.L.C.90,000$0.47M0.2%N/A0.058%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC31,881$0.17M0.0%+127.8%0.020%Search for SEC Filing on Google Icon
11/16/2021Toroso Investments LLC10,554$55K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.76,300$0.39M0.0%-96.3%0.049%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC57,953$0.30M0.0%+485.4%0.037%Search for SEC Filing on Google Icon
11/15/2021Man Group plc148,305$0.77M0.0%+44.2%0.095%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP1,553,800$8.03M0.0%N/A0.995%Search for SEC Filing on Google Icon
11/15/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%Search for SEC Filing on Google Icon
11/15/2021Wealthspire Advisors LLC11,750$61K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/15/2021Virtus ETF Advisers LLC47,350$0.25M0.1%-5.0%0.030%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP444,887$2.30M0.2%N/A0.285%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP484,782$2.51M0.3%-5.6%0.311%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP23,609$0.12M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/12/2021Blueshift Asset Management LLC11,933$62K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/10/2021US Bancorp DE5,729$29K0.0%+403.0%0.004%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.330,378$1.71M0.0%-13.3%0.212%Search for SEC Filing on Google Icon
11/10/2021KBC Group NV45,900$0.24M0.0%+77.2%0.029%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.41,991$0.22M0.0%-15.9%0.027%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC740,915$3.83M0.0%-9.5%0.475%Search for SEC Filing on Google Icon
11/10/2021Healthcare of Ontario Pension Plan Trust Fund60,300$0.31M0.0%-94.1%0.039%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,260,872$6.52M0.0%+28.5%0.808%Search for SEC Filing on Google Icon
11/5/2021Lindbrook Capital LLC8,667$45K0.0%+31.1%0.006%Search for SEC Filing on Google Icon
11/5/2021Daiwa Securities Group Inc.15,382$80K0.0%+5,908.6%0.010%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC85,163$0.44M0.0%-63.9%0.055%Search for SEC Filing on Google Icon
10/29/2021Vontobel Holding Ltd.103,000$0.53M0.0%+3.0%0.066%Search for SEC Filing on Google Icon
10/19/2021Vigilare Wealth Management99,950$0.52M0.3%+84.2%0.064%Search for SEC Filing on Google Icon
10/19/2021Baillie Gifford & Co.12,824,980$66.31M0.0%+9.6%8.217%Search for SEC Filing on Google Icon
10/13/2021FNY Investment Advisers LLC12,500$64K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP1,539,435$6.56M1.8%+68.1%0.986%Search for SEC Filing on Google Icon
8/17/2021Itau Unibanco Holding S.A.8,892$38K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC930,415$3.96M0.0%-42.4%0.598%Search for SEC Filing on Google Icon
8/17/2021Man Group plc102,868$0.44M0.0%-23.9%0.066%Search for SEC Filing on Google Icon
8/17/2021PFM Health Sciences LP3,627,900$15.46M0.5%+45.0%2.334%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC13,997$60K0.0%-63.4%0.009%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.2,059,092$8.77M0.0%+4.1%1.324%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC9,899$42K0.0%+135.7%0.006%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley2,288,531$9.75M0.0%-51.6%1.472%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC355,853$1.52M0.0%+0.9%0.229%Search for SEC Filing on Google Icon
8/16/2021State Street Corp259,582$1.11M0.0%-36.3%0.167%Search for SEC Filing on Google Icon
8/16/2021Avoro Capital Advisors LLC2,024,400$8.62M0.2%-43.0%1.302%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.381,161$1.62M0.0%+708.6%0.245%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC303,495$1.29M0.0%+200.5%0.195%Search for SEC Filing on Google Icon
8/13/2021Sigma Planning Corp10,209$43K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC128,200$0.55M0.1%N/A0.082%Search for SEC Filing on Google Icon
8/13/2021Stifel Financial Corp43,349$0.19M0.0%+29.0%0.028%Search for SEC Filing on Google Icon
8/13/2021ProShare Advisors LLC24,520$0.10M0.0%+30.1%0.016%Search for SEC Filing on Google Icon
8/12/2021Healthcare of Ontario Pension Plan Trust Fund1,027,000$4.38M0.0%+124.5%0.661%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adaptimmune Therapeutics logo
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. The company is also developing ADP-A2AFP, which is in phase I clinical trials for hepatocellular carcinoma; and ADP-A2M4CD8, which is in phase I clinical trial for SPEAR T-cells focusing on treating patients with lung, gastroesophageal, head and neck, ovarian, and bladder cancers. It has a collaboration and license agreement with GSK; third party collaborations with Noile-Immune Biotech Inc., Alpine Immune Sciences, Inc., and National Center for Cancer Immune Therapy in Denmark; strategic alliance agreement with the MD Anderson Cancer Center; and co-development and co-commercialization agreement with Universal Cells, Inc. Adaptimmune Therapeutics plc also has a strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic T-cell therapies utilizing aß T-cell receptors. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Read More on Adaptimmune Therapeutics

Today's Range

Now: $1.20
Low: $1.18
High: $1.22

50 Day Range

MA: $1.93
Low: $1.17
High: $2.41

52 Week Range

Now: $1.20
Low: $1.10
High: $5.95

Volume

3,740 shs

Average Volume

618,833 shs

Market Capitalization

$196.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Who are the company insiders with the largest holdings of Adaptimmune Therapeutics?

Adaptimmune Therapeutics' top insider shareholders include:
  1. Gavin Wood (CFO)
  2. John Lunger (Insider)
  3. Adrian Rawcliffe (CEO)
  4. Elliot Norry (Insider)
  5. William C Bertrand Jr (COO)
  6. William C Bertrand, Jr (COO)
Learn More about top insider investors at Adaptimmune Therapeutics.

Who are the major institutional investors of Adaptimmune Therapeutics?

Adaptimmune Therapeutics' top institutional shareholders include:
  1. Baillie Gifford & Co. — 9.46%
  2. JPMorgan Chase & Co. — 0.91%
  3. Point72 Asset Management L.P. — 0.40%
  4. Renaissance Technologies LLC — 0.31%
  5. State Street Corp — 0.23%
  6. ExodusPoint Capital Management LP — 0.18%
Learn More about top institutional investors of Adaptimmune Therapeutics stock.

Which institutional investors are selling Adaptimmune Therapeutics stock?

In the last quarter, ADAP stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Renaissance Technologies LLC
  3. Rafferty Asset Management LLC
  4. State Street Corp
  5. Baillie Gifford & Co.
  6. Virtu Financial LLC
  7. Group One Trading L.P.
During the last year, company insiders that have sold Adaptimmune Therapeutics company stock include:
  1. Gavin Wood (CFO)
  2. John Lunger (Insider)
  3. Adrian Rawcliffe (CEO)
  4. Elliot Norry (Insider)
Learn More investors selling Adaptimmune Therapeutics stock.

Which institutional investors are buying Adaptimmune Therapeutics stock?

During the last quarter, ADAP stock was acquired by institutional investors including:
  1. ExodusPoint Capital Management LP
  2. Alps Advisors Inc.
  3. JPMorgan Chase & Co.
  4. Point72 Asset Management L.P.
  5. Jane Street Group LLC
  6. Vigilare Wealth Management
  7. Hunter Associates Investment Management LLC
Within the previous year, these company insiders have bought Adaptimmune Therapeutics stock:
  1. Gavin Wood (CFO)
  2. John Lunger (Insider)
Learn More investors buying Adaptimmune Therapeutics stock.